Skip to main content
. 2000 Nov 7;97(23):12776–12781. doi: 10.1073/pnas.97.23.12776

Table 2.

Quantitative RT-PCR analysis of HOX expression

Controls ΔCt
A1 A7 A9 B9 A10 WNT7A
 302-1 NHBE 8.9 Ab. Ab. 16.1 15.4 4.5
 604-2 NHBE 9.8 Ab. Ab. 18.0 15.6 5.0
 2523 NHBE 8.9 Ab. Ab. 15.0 15.8 4.8
 5214 T-Ag, p83 17.3 Ab. Ab. 15.7 15.4 16.6
 Nonmalignant Lung 10.8 7.7 15.3 12.9 11.6 6.1
 HUVEC Endothel. 12.8 8.7 10.1 10.0 9.1 Ab.
Cell lines
 GLC20 SCLC 11.1 6.8 11.1 6.8 6.9 8.2
 H187 SCLC 11.5 7.1 9.7 9.8 7.6 19.5
 H1048 SCLC 10.8 7.5 9.2 10.1 7.8 15.3
 H1341 SCLC 12.4 15.2 8.1 8.3 10.6 15.4
 H1607 SCLC 9.3 13.3 18.1 6.7 15.5 5.9
 N177 SCLC 17.8 10.3 11.3 19.0 9.2 15.4
 H82 SCLC 11.7 11.1 17.6 8.4 9.9 19.9
 H196 SCLC 8.9 12.9 19.7 11.5 6.5 19.3
 H433 SCLC 12.0 12.0 10.6 11.9 7.4 15.8
 H437 SCLC 9.1 9.9 15.5 9.2 8.4 18.8
 H1264 Adeno. 14.8 9.5 9.7 8.7 8.6 19.2
 H1648 Adeno. 8.5 12.8 20.6 11.4 15.5 10.3
 H2122 Adeno. 11.4 12.4 19.6 11.0 15.0 11.5
 A549 Adeno. 12.4 9.7 14.3 8.4 9.4 14.6
 H460 Lg. Cell 14.1 10.1 9.2 6.4 9.0 20.3
 H661 Lg. Cell 10.1 5.6 16.2 6.6 7.7 14.7
 H1334 Lg. Cell 10.1 13.7 16.4 10.4 8.2 9.3
 H157 Squam. 11.5 15.5 18.8 9.5 13.1 19.9
 H226 Squam. 11.5 15.3 14.3 9.4 6.7 18.8
 H28 Meso. 13.4 14.9 20.6 6.8 14.9 18.7
 H513 Meso. 7.8 7.2 14.6 6.7 5.9 6.2
 H290 Meso. 8.8 12.5 12.5 8.3 6.8 9.8
 H322 BronchAlv. 9.8 14.5 16.7 13.4 9.0 7.6
 H292 Carcinoid 9.6 12.2 9.9 11.9 7.3 6.8
 H720 Carcinoid 12.0 7.4 14.9 6.4 6.9 19.4
Direct tumors
 tumor03 Adeno. 8.6 8.8 9.1 6.8 6.1 14.5
 tumor07 Adeno. 14.3 13.9 12.8 16.9 16.2 15.7
 tumor08 Adeno. 13.5 11.2 13.0 15.8 5.9 11.1
 3279-T Adeno. 11.0 10.0 17.7 9.5 10.1 7.4
 3483-T Adeno. 12.1 10.0 16.8 9.4 8.7 8.8
 3662-T Adeno. 11.6 12.2 17.6 14.4 14.0 14.0
 3663-T Adeno. 7.9 10.6 13.4 12.2 8.3 9.0
 3740-T Adeno. 10.6 9.1 16.6 13.2 8.6 9.8
 6160-T Adeno. 13.1 15.4 18.4 15.5 14.4 11.2
 6802-T Adeno. 9.5 15.5 14.6 5.7 9.0 8.1
 7075-T Adeno. 13.8 16.5 18.0 15.5 14.3 13.4
 7257-T Adeno. 12.2 13.5 15.6 11.7 10.6 10.4
 7332-T Adeno. 10.4 13.7 14.3 11.8 11.8 10.6
 7343-T Adeno. 14.9 16.2 18.2 12.8 13.9 11.3
 7345-T Adeno. 10.9 13.3 15.9 15.1 8.4 13.0
 7566-T Adeno. 12.5 15.0 16.4 5.4 9.2 17.0
 2520-T BronchAlv. 12.4 12.9 16.1 7.5 11.6 9.9
 6157-T Carcinoid 15.1 16.2 18.3 16.1 14.7 12.3
 6374-T Carcinoid 15.4 16.8 17.8 15.3 15.9 12.0
 2665-T Carcinoid 14.6 16.8 18.2 16.8 14.0 18.0
 6206-T Lg. Cell 8.4 12.1 16.2 8.8 7.3 15.4
 7362-T Meso. 9.4 14.3 12.7 12.3 7.2 18.0
 tumor02 Squam. 9.5 10.4 12.7 13.4 8.5 7.3
 tumor11 Squam. 12.1 10.4 12.9 12.6 8.5 12.2
 tumor12 Squam. 10.3 13.2 12.9 13.5 8.6 15.8
 tumor13 Squam. 10.6 9.0 13.9 13.6 8.9 17.0
 tumor14 Squam. 11.8 10.2 17.0 15.0 8.9 10.1
 tumor15 Squam. 10.3 10.0 10.5 16.1 9.4 8.2
 tumor17 Squam. 13.0 9.3 10.7 13.4 8.7 8.1
 3041-T Squam. 11.0 8.2 16.8 13.2 12.0 9.4
 6406-T Squam. 9.6 15.8 17.0 11.0 8.8 12.5
 6792-T Squam. 11.7 16.1 17.2 16.4 8.6 13.1
 7259-T Squam. 10.0 12.6 12.8 9.7 9.7 12.8
 7466-T Squam. 10.6 15.2 15.4 13.7 12.4 8.0
 7565-T Squam. 9.4 12.6 13.9 9.1 8.3 9.5

Values represent ΔCts obtained from 6 controls, 25 lung tumor cell lines, and 35 resected tumors, as indicated. Nonmalignant lung values represent the average of 25 independent resections, which were tumor free. The All HOX column contains the sum of ΔCt values for the 5 HOX loci analyzed. The average standard deviation was 0.12 cycles.